Finance

Beta
Lists
GL:NYSE
Globe Life Inc
$156.01
+0.94%
(+1.46) 1D
Jun 5, 9:35:07 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GL...
Open
$156.01
High
$156.01
Low
$156.01
Mkt. cap
12.11B
Avg. vol.
574.51K
Volume
3.00
Dividend
0.85%
Quarterly dividend
$0.33
Ex-dividend date
Jul 6, 2026
P/E ratio
10.78
52-wk high
$157.92
52-wk low
$116.73
EPS
$14.47
Beta
0.49
Shares outstanding
77.64M
No. of employees
4K
Open
$156.01
High
$156.01
Low
$156.01
Mkt. cap
12.11B
Avg. vol.
574.51K
Volume
3.00
Dividend
0.85%
Quarterly dividend
$0.33
Ex-dividend date
Jul 6, 2026
P/E ratio
10.78
52-wk high
$157.92
52-wk low
$116.73
EPS
$14.47
Beta
0.49
Shares outstanding
77.64M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to GL in the past 3 months
Strong Buy
Buy
7
Hold
2
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for GL in the last 3 months.
Highest
Current $156.01
$199.00 (+27.56%)
Average
$174.11 (+11.60%)
Lowest
$148.00 (-5.13%)
News stories
From sources across the web
Profile
Globe Life Inc. is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas. Wikipedia
About Globe Life Inc
CEOJ. Matthew Darden | Frank M Svoboda
Employees3.7K
Founded1900
HeadquartersMcKinney, Texas, United States
SectorInsurance
Last report
Apr 23, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$3.43 / $3.48
-1.35%miss
Revenue / Est. (USD)
1.56B / 1.57B
-0.44%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.48B
1.51B
1.52B
1.56B
Cost of goods sold
1.02B
888.19M
1.03B
1.08B
Cost of revenue
1.02B
888.19M
1.03B
1.08B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
7.10M
-
Operating expense
103.64M
108.97M
117.18M
111.51M
Total operating expenses
1.13B
997.16M
1.15B
1.19B
Operating income
352.83M
515.82M
368.39M
370.35M
Other non operating income
-
-
-
-
EBT including unusual items
313.30M
477.10M
329.49M
334.13M
EBT excluding unusual items
317.95M
479.69M
333.18M
336.35M
Income tax expense
60.55M
89.26M
63.41M
63.61M
Effective tax rate
19.33%
18.71%
19.24%
19.04%
Other operating expenses
89.60M
94.37M
97.39M
97.91M
Net income
252.75M
387.84M
266.08M
270.53M
Net profit margin
17.06%
25.63%
17.51%
17.35%
Earnings per share
3.27
4.81
3.39
3.43
Interest and investment income
-
-
-
-
Interest expense
-34.88M
-36.13M
-35.21M
-34.00M
Net interest expenses
-34.88M
-36.13M
-35.21M
-34.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
359.58M
522.58M
375.89M
377.85M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more